REALIZING THE POWER OF RED
LIVE

Serial Number

88302047

Owner

Rubius Therapeutics, Inc.

Attorney

Christina M. Licursi

First Use Date

Oct 15, 2019

Filing Date

Feb 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

REALIZING THE POWER OF RED Trademark

Serial Number: 88302047 • Registration: 6025283

REALIZING THE POWER OF RED is a trademark filed by Rubius Therapeutics, Inc. on February 14, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Rubius Therapeutics, Inc. (10 trademarks)

Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

February 14, 2019

Registration Date

March 31, 2020

First Use Anywhere

October 15, 2019

First Use in Commerce

October 15, 2019

Published for Opposition

June 4, 2019

Goods & Services

Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders

Scientific research, pharmaceutical research, medical research, technical consultation and product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents and medical devices

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 31, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 25, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 24, 2020 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 31, 2020 SUPC
SOU EXTENSION 1 GRANTED
Jan 31, 2020 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2020 AITU
USE AMENDMENT FILED
Jan 28, 2020 IUAF
SOU EXTENSION 1 FILED
Jan 28, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 28, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Jan 28, 2020 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 9, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 9, 2019 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2019 CNSA
ASSIGNED TO EXAMINER
Apr 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2019 NWOS
NEW APPLICATION ENTERED
Feb 18, 2019 NWAP